Sanger sequencing remains a foundational technique in molecular biology, serving as the primary method for determining the precise order of nucleotides within a DNA molecule. Developed by Frederick Sanger in 1977, this dideoxy chain-termination approach enabled the first complete genome sequencing and continues to be the gold standard for accuracy and reliability. The purpose of Sanger sequencing extends beyond simple verification, providing critical data for confirming genetic variants, validating novel findings from high-throughput technologies, and supporting essential applications in clinical diagnostics. Its enduring utility stems from a unique combination of high fidelity, long read lengths, and an unmatched track record in producing trusted results.
Core Methodology and Principle
The fundamental purpose of Sanger sequencing is to identify the exact sequence of adenine (A), thymine (T), cytosine (C), and guanine (G) in a target DNA strand. This is achieved through a modified polymerase chain reaction (PCR) that incorporates chain-terminating dideoxynucleotides (ddNTPs). Each ddNTP lacks a 3'-hydroxyl group, preventing the addition of subsequent nucleotides and creating a set of DNA fragments that terminate at every possible position corresponding to a specific base. By running these fragments through capillary electrophoresis, the sequence is read in a linear order from the smallest to the largest fragment.
Verification and Confirmation of Genetic Variants
A primary purpose of Sanger sequencing is the orthogonal validation of results generated by next-generation sequencing (NGS) and other high-throughput platforms. NGS technologies can sometimes produce false positives due to artifacts, alignment errors, or low-frequency contamination. Sanger sequencing acts as a definitive confirmatory tool, resolving uncertainty by providing a high-resolution, visual readout of the specific region of interest. This is particularly crucial in clinical settings where a single incorrect call can have significant implications for patient care and treatment planning.
Targeted Analysis in Clinical Diagnostics
Applications in Medical Genetics
In clinical laboratories, the purpose of Sanger sequencing is to diagnose monogenic disorders caused by mutations in a single gene. Conditions such as cystic fibrosis, sickle cell anemia, and hereditary cancers like Lynch syndrome are routinely analyzed using this method. Its targeted nature allows for the focused examination of known pathogenic variants within exons and splice sites, offering a cost-effective and efficient solution for definitive diagnosis, carrier screening, and prenatal testing where whole-genome or whole-exome sequencing may be unnecessary.
Ensuring Accuracy and Compliance
Regulatory and accreditation bodies, such as the Clinical Laboratory Improvement Amendments (CLIA), often mandate Sanger sequencing for confirmation due to its proven accuracy and low error rate. The technology’s ability to produce a clear, unambiguous electropherogram makes it an essential component of quality control and compliance. For legal and forensic applications, the purpose of Sanger sequencing is to provide defensible, court-admissible data that meets the highest standards of reproducibility and chain-of-custody, ensuring the integrity of the genetic evidence.
Refining Research and Drug Development
In academic and pharmaceutical research, Sanger sequencing serves the purpose of validating genetic constructs and confirming the identity of cloned inserts. Before investing in large-scale experiments, researchers rely on this method to verify the correct assembly of plasmids, site-directed mutagenesis, and the genetic makeup of cell lines. It remains an indispensable tool for characterizing novel mutations, studying gene expression regulation, and ensuring the genetic fidelity of biological reagents used in drug discovery pipelines.
Long-Read Amplicon Sequencing
While NGS excels at sequencing short fragments across a genome, Sanger sequencing is uniquely suited for analyzing longer amplicons with high precision. The purpose of Sanger sequencing in this context is to provide reliable data across regions that are difficult for short-read technologies to resolve, such as regions with high GC content or complex repeat structures. This capability ensures that critical genomic regions, which might be missed or misassembled by other methods, are accurately characterized.
